The NIPBL Gene Cornelia de Lange Syndrome Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the NIPBL gene, which are closely associated with Cornelia de Lange Syndrome (CdLS) Type 1. This syndrome is a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and various physical abnormalities. The test is crucial for confirming a diagnosis of CdLS Type 1, enabling appropriate management and care for affected individuals.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory to detect any genetic alterations in the NIPBL gene. Positive identification of a mutation can assist in guiding treatment options, inform about the risk of recurrence in future pregnancies, and support families in accessing genetic counseling services. Conducted at DNA Labs UAE, this genetic test represents a vital step towards personalized medicine for patients with Cornelia de Lange Syndrome Type 1, providing them with targeted interventions and support.
The "SMC1A Gene Cornelia de Lange Syndrome Type 2 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, aimed at detecting mutations in the SMC1A gene, which are associated with Cornelia de Lange Syndrome (CdLS) Type 2. Cornelia de Lange Syndrome is a rare genetic disorder that can affect multiple parts of the body and is characterized by distinctive facial features, growth delays, intellectual disability, and limb defects. The test is crucial for early diagnosis and management of the syndrome, allowing for tailored care and interventions to improve the quality of life for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations linked to this condition. By offering this test, DNA Labs UAE provides essential support to families seeking answers about this complex syndrome, facilitating access to genetic counseling and appropriate medical care.
The SMC3 Gene Cornelia de Lange Syndrome Type 3 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the SMC3 gene, which are associated with Cornelia de Lange Syndrome Type 3 (CdLS3). Cornelia de Lange Syndrome is a rare genetic disorder that can affect multiple parts of the body and is characterized by slowed growth, intellectual disability, skeletal abnormalities, and distinctive facial features. The Type 3 variant of the syndrome, associated with mutations in the SMC3 gene, represents a specific subset within this spectrum.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the SMC3 gene. A positive result may confirm a diagnosis of Cornelia de Lange Syndrome Type 3, providing crucial information for the management and treatment of the condition. This genetic test is an essential tool for families seeking answers about developmental delays, growth issues, or other symptoms suggestive of CdLS3, enabling them to make informed decisions about care and support for their loved ones.
The RAD21 gene plays a significant role in human genetics, particularly in relation to Cornelia de Lange Syndrome (CdLS), a rare genetic disorder. The RAD21 gene is crucial for maintaining the stability of the genetic material within cells. Mutations in this gene can lead to various genetic disorders, including Cornelia de Lange Syndrome Type 4. This particular type of CdLS is characterized by distinctive facial features, growth delays, intellectual disability, and limb abnormalities, among other symptoms.
To diagnose this specific subtype of CdLS, genetic testing targeting the RAD21 gene is conducted. DNA Labs UAE offers this specialized genetic test to identify mutations in the RAD21 gene that are indicative of Cornelia de Lange Syndrome Type 4. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab for the presence of mutations in the RAD21 gene.
The cost of the RAD21 gene Cornelia de Lange Syndrome Type 4 genetic test at DNA Labs UAE is 4400 AED. This cost encompasses the process of sample collection, genetic analysis, and the provision of a detailed report by healthcare professionals. The report not only confirms the diagnosis but also provides valuable information for the management and treatment of the condition. This test is a crucial step for families seeking answers about CdLS and planning for the care of affected individuals.
The HDAC8 gene Cornelia de Lange Syndrome Type 5 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the HDAC8 gene, which are associated with Cornelia de Lange Syndrome (CdLS) type 5. Cornelia de Lange Syndrome is a rare genetic disorder that can lead to a variety of developmental anomalies, including growth delays, intellectual disability, limb defects, and distinctive facial features. The HDAC8 gene plays a crucial role in the development of various tissues and organs during embryonic development, and mutations in this gene can disrupt normal growth patterns, leading to the symptoms observed in CdLS.
The test is performed using a sample of the patient's DNA, which is analyzed for specific genetic variations indicative of the syndrome. This precise genetic testing helps in confirming the diagnosis, enabling targeted interventions, and providing essential information for family planning. The cost of the HDAC8 gene Cornelia de Lange Syndrome Type 5 genetic test at DNA Labs UAE is 4400 AED. This test is a valuable tool for families seeking answers about this complex condition, offering them a clearer understanding of their genetic status and the implications for their health and future.
The "TMCO1 Gene Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation Syndrome Genetic Test" is a specialized diagnostic tool used to identify mutations in the TMCO1 gene, which have been associated with a rare genetic disorder. This condition is characterized by distinctive craniofacial features, skeletal abnormalities, and intellectual disability. The test is crucial for the accurate diagnosis of the syndrome, enabling healthcare providers to develop a personalized treatment and management plan for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA to look for specific mutations in the TMCO1 gene that are linked to the syndrome. The process is comprehensive, ensuring a high degree of accuracy in the diagnosis of this complex condition.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to conduct this advanced genetic analysis. For families and individuals facing the possibility of this rare syndrome, the test offers valuable insights, guiding medical and support strategies to improve quality of life and manage the syndrome's various challenges.
The FGFR2 Gene Craniofacial-Skeletal-Dermatologic Dysplasia Genetic Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FGFR2 gene. These mutations are known to cause a range of developmental disorders affecting the craniofacial structure, skeletal system, and skin. The FGFR2 gene plays a crucial role in cell division, growth, and repair, and abnormalities within this gene can lead to various syndromes, including Apert Syndrome, Crouzon Syndrome, and Pfeiffer Syndrome, among others. These conditions are characterized by premature fusion of skull bones, abnormalities in the hands and feet, and a range of dermatologic and skeletal issues.
The test is conducted using a sample of the patient's DNA, extracted from a blood sample or cheek swab, and employs state-of-the-art genetic sequencing technology to identify mutations in the FGFR2 gene. This precise diagnostic approach allows for early detection and a better understanding of the condition, facilitating tailored treatment and management plans for affected individuals.
Priced at 4400 AED, the FGFR2 Gene Craniofacial-Skeletal-Dermatologic Dysplasia Genetic Test is a valuable resource for families and individuals seeking clarity on genetic conditions affecting craniofacial, skeletal, and skin health. DNA Labs UAE is committed to providing accurate, comprehensive genetic testing services to help improve the lives of those dealing with genetic disorders.
The FGFR3 Gene Crouzon Syndrome with Acanthosis Nigricans Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the FGFR3 gene, which are linked to Crouzon syndrome with acanthosis nigricans. Crouzon syndrome is a genetic disorder characterized by the premature fusion of certain skull bones, leading to an abnormal shape of the head and face. Acanthosis nigricans, associated with this condition, involves skin changes that produce dark, thickened patches around the body. The test, priced at 4400 AED, utilizes advanced genetic sequencing technologies to identify the specific mutations in the FGFR3 gene, providing crucial information for accurate diagnosis, management, and genetic counseling for affected individuals and their families. This test is pivotal for early intervention and treatment planning, aiming to improve the quality of life for those diagnosed with this rare genetic condition.
The "ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test" is a specialized diagnostic assessment conducted at DNA Labs UAE, aimed at identifying mutations in the ATR gene. These mutations are known to be associated with an increased risk of developing cutaneous telangiectasia and various forms of cancer, highlighting the importance of early detection for individuals with a family history of these conditions. The test is crucial for families looking to understand their genetic predisposition to these health issues, allowing for early intervention and management strategies to be implemented.
The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the ATR gene. Results from this test can provide invaluable information for affected individuals and their healthcare providers, enabling personalized healthcare plans that may include increased surveillance for cancer, preventive measures, and targeted therapies based on the genetic findings.
The cost of the ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary to understand an individual's genetic risk factors. Given the potential health implications and the opportunity for early preventive actions, the test represents a valuable tool for those with a family history suggestive of a genetic predisposition to these conditions.
The FBLN5 Gene Cutis Laxa Type 1A Autosomal Recessive Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FBLN5 gene, which are known to cause Cutis Laxa Type 1A. Cutis Laxa is a rare genetic disorder characterized by severely loose and sagging skin, alongside other possible systemic involvement affecting lungs, arteries, and the gastrointestinal system. Type 1A is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.
The test is crucial for early diagnosis, enabling appropriate management and genetic counseling for affected families. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the FBLN5 gene that are indicative of Cutis Laxa Type 1A.
Priced at 4400 AED, this genetic test is an important resource for individuals with a family history of Cutis Laxa or those showing symptoms of the disorder, providing them with critical information for managing their health and making informed decisions about their future and that of their potential offspring. DNA Labs UAE, by offering this test, plays a vital role in the early detection and management of this rare genetic condition.
